Search Results - "Lydiard, R.Bruce"

A potential role for thalamocingulate circuitry in human maternal behavior by LORBERBAUM, Jeffrey P, NEWMAN, John D, HORWITZ, Amy R, DUBNO, Judy R, LYDIARD, R. Bruce, HAMNER, Mark B, BOHNING, Daryl E, GEORGE, Mark S

“…Little is known about the regional brain basis of human maternal behavior. To understand this better, we have been examining brain activity in mothers…”
Get full text

Brain circuits in panic disorder by Coplan, Jeremy D, Lydiard, R.Bruce

“…This paper reviews the pathophysiology of panic disorder (PD), within the context of newly described “fear circuitries,” which have been well characterized in…”
Get full text

Experience with anxiety and depression treatment studies: implications for designing irritable bowel syndrome clinical trials by Lydiard, R B, Falsetti, S A

“…This report highlights various considerations regarding the potential effects of concurrent psychiatric conditions and a history of abuse in patient volunteers…”
Get more information

Insight and treatment outcome in obsessive-compulsive disorder by Eisen, Jane L., Rasmussen, Steven A., Phillips, Katharine A., Price, Lawrence H., Davidson, Jonathan, Lydiard, R.Bruce, Ninan, Philip, Piggott, Teresa

“…To determine whether (1) insight in obsessive-compulsive disorder (OCD) improves when OCD symptoms improve, and whether (2) degree of insight in OCD predicts…”
Get full text

An overview of generalized anxiety disorder: disease state—appropriate therapy by Lydiard, R.Bruce

“…Objective: This article reviews the prevalence, diagnosis, and treatment of generalized anxiety disorder (GAD). Background: Patients with GAD often present to…”
Get full text

Assessing abuse liability in clinical trials by Brady, Kathleen T., Lydiard, R.Bruce, Brady, Joseph V.

“…In this article, the use of data collected in registration-focused clinical trials to provide information concerning abuse liability of compounds under…”
Get full text

Placebo-controlled trial of the CCK-B antagonist, CI-988, in panic disorder by Pande, Atul C, Greiner, Martha, Bammert Adams, Judith, Lydiard, R.Bruce, Pierce, Mark W

“…Background: Based on the induction of panic-like symptoms by infusion of cholecystokinin (CCK) peptide in normals and panic disorder patients, it has been…”
Get full text

Noradrenergic Function and Clinical Outcome in Antidepressant Pharmacotherapy by Miller, Helen L, Ekstrom, R.David, Mason, George A, Lydiard, R.Bruce, Golden, Robert N

“…Controversy remains regarding the role of noradrenergic systems in determining clinical response to antidepressant pharmacotherapy. Pineal gland production of…”
Get full text

Elevated plasma thymopoietin associated with therapeutic nonresponsiveness in major depression by Goldstein, Gideon, Fava, Maurizio, Culler, Michael, Fisher, Alan, Rickels, Karl, Lydiard, R.Bruce, Rosenbaum, Jerrold

“…Background: Stress predisposes to major depression, and hyperactivity of the stress-activated hypothalamic-pituitary-adrenal (HPA) axis occurs in this disease…”
Get full text

Sleep Deprivation in Social Phobia and Generalized Anxiety Disorder by Labbate, Lawrence A, Johnson, Michael R, Lydiard, R.Bruce, Brawman-Mintzer, Olga, Emmanuel, Naresh, Crawford, Marsha, Kapp, Rebecca, Ballenger, James C

“…Background: Sleep deprivation has been shown to improve depressive symptoms in some patients with major depressive disorder, but it has not been tested in…”
Get full text

Plasma and CSF HVA levels in panic patients with comorbid social phobia by Johnson, M R, Lydiard, R B, Zealberg, J J, Fossey, M D, Ballenger, J C

Get more information

Brain MRI in obsessive-compulsive disorder by Kellner, C H, Jolley, R R, Holgate, R C, Austin, L, Lydiard, R B, Laraia, M, Ballenger, J C

“…Magnetic resonance imaging (MRI) brain scans were performed on 12 patients with obsessive-compulsive disorder and 12 healthy controls. Measurements of the area…”
Get more information

Predictors of response to alprazolam and placebo in patients with panic disorder by Woodman, C L, Noyes, Jr, R, Ballenger, J C, Lydiard, R B, Sievers, G, Mihalko, D

“…Date from a panic disorder treatment study with 506 patients, comparing alprazolam and placebo in a double-blind manner for 8 weeks, were analyzed to identify…”
Get more information

Antidepressants in panic disorder and agoraphobia by Lydiard, R B, Ballenger, J C

“…A survey of the literature on the use of antidepressants for treating patients with panic disorder and agoraphobia with panic attacks suggests that both…”
Get more information

Plasma pyridoxal phosphate in anxiety disorders by Emmanuel, N P, Lydiard, R B, Reynolds, R D, Roberts, J, Johnson, M, Mintzer, O, Ballenger, J C

“…One hundred and eighty-nine subjects with either generalized anxiety disorder, panic disorder, or obsessive-compulsive disorder were evaluated for plasma…”
Get more information

A comparison of the effects of imipramine and fluvoxamine on the thyroid axis by Brady, K T, Lydiard, R B, Kellner, C H, Joffe, R, Laird, L K, Morton, W A, Steele, T E

Get more information

CSF prostaglandin-E in agoraphobia with panic attacks by Anton, R F, Ballenger, J C, Lydiard, R B, Laraia, M T, Howell, E F, Gold, P W

“…Prostaglandins are thought to act as neuromodulators of both central catecholamine and endocrine systems. Abnormalities of these systems have been described in…”
Get more information

Precursor amino acid concentrations in normal weight bulimics and normal controls by Lydiard, R B, Brady, K T, O'Neil, P M, Schlesier-Carter, B, Hamilton, S, Rogers, Q, Ballenger, J C

“…1. CNS serotonergic neurotransmission has been implicated in the control of appetitive behavior. The ratio of plasma tryptophan (TRP) to other large neutral…”
Get more information